These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1350218)

  • 1. Review of clinical trials of low molecular weight heparins.
    Bergqvist D
    Eur J Surg; 1992 Feb; 158(2):67-78. PubMed ID: 1350218
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 5. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
    Turpie AG
    Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy and tolerance of the low molecular weight heparin fraction CY 216 in preventing postoperative venous thromboembolism].
    Kakkar VV
    Med Klin Suppl; 1986 Oct; 3():13-6. PubMed ID: 3550366
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.
    Collins R; Scrimgeour A; Yusuf S; Peto R
    N Engl J Med; 1988 May; 318(18):1162-73. PubMed ID: 3283548
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of venous thrombosis after elective hip surgery.
    Turpie AG; Kher A
    Orthopedics; 1998 Dec; 21(12):1275-81. PubMed ID: 9867302
    [No Abstract]   [Full Text] [Related]  

  • 10. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Can the individual risk of the patient for thromboembolic complications be estimated? What references can be used for differential therapeutic procedure?].
    Voigt J
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1157-61. PubMed ID: 1983503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis of venous thromboembolism: the old and the new.
    Pini M
    Haematologica; 1995; 80(2 Suppl):66-77. PubMed ID: 7628774
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
    Daiss W; Dölle W
    Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
    [No Abstract]   [Full Text] [Related]  

  • 15. An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism.
    Haas S; Blümel G
    Semin Thromb Hemost; 1989 Oct; 15(4):424-34. PubMed ID: 2554503
    [No Abstract]   [Full Text] [Related]  

  • 16. Basic data related to venous thromboembolism.
    Clagett GP
    Ann Vasc Surg; 1988 Oct; 2(4):402-5. PubMed ID: 3066391
    [No Abstract]   [Full Text] [Related]  

  • 17. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.
    Urlep-Salinović V; Jelatancev B; Gorisek B
    Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low molecular weight heparin--preventive supplementation against postoperative venous thromboembolism].
    Bergqvist D
    Lakartidningen; 1990 Feb; 87(8):562-4. PubMed ID: 2155361
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploring the role of low-molecular-weight heparins in pregnancy.
    Greer IA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1024-5. PubMed ID: 11484301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.